Apexigen, Inc. — Form D
Apexigen, Inc. of SAN CARLOS, CA, a company, filed a Form D exempt-offering notice with the SEC on 2019-12-11. The offering totals $70.0M, of which $45.8M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2019-12-11
- Form: D
- Accession: 0001575867-19-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $70.0M
- Amount sold: $45.8M
- Remaining: $24.2M
- Investors: 19
- Date of first sale: 2019-11-27
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-355331
Issuer
- Name: Apexigen, Inc.
- CIK: 0001575867
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2010
- Address: 75 SHOREWAY RD., SUITE C, SAN CARLOS, CA, 94070
- Phone: (650) 931-6236
Officers, directors & promoters (11)
| Name | Role | Location |
|---|
| Herb Cross | Director | Redwood City, CA |
| Kenneth Fong | Director | San Carlos, CA |
| KAREN LIU | Director | SAN DIEGO, CA |
| William Rutter | Director | Palm Springs, CA |
| Scott Smith | Director | New York, NY |
| Xiaodong Yang | Director | San Carlos, CA |
| Dan Zabrowski | Director | Fort Worth, TX |
| Ovid Trifan | Executive Officer | San Carlos, CA |
| Amy Wong | Executive Officer | CUPERTINO, CA |
| Xiaodong Yang | Executive Officer | San Carlos, CA |
| GEORGE LEE | Director | New York, NY |
Other filings by this issuer (1)
More